Walmark Further Expands Its Portfolio by Acquiring Pneumolan from Novascon Pharmaceuticals

Walmark a.s. (“Walmark” or the “Company”), a major Consumer Healthcare player in Central and Eastern Europe with a leading position in dietary supplements, jointly controlled by MidEuropa and the founding Walach family announced today that it has further expanded its product portfolio in Poland by acquiring a range of products marketed under the Pneumolan brand…

Read More